Isolated hyperthermic liver perfusion with high dose tumor necrosis factoralpha in pigs: An experimental study in preparation of clinical use

Isolated hyperthermic perfusion of the liver was performed for 45 min in 27 pigs via hepatic artery and portal vein at mean inflow temperatures betwee n 40.7 and 41.2 degrees C, In two study groups B and C (n = 9 pigs each) 50 mu g recombinant human tumor necrosis factor-alpha (rhTNF alpha) per kg bo dy weight were added to the perfusate, whereas in a control group A liver p erfusion was done without rhTNF alpha, Before reperfusion the livers were w ashed out with Ringer's solution in all groups followed by a protein soluti on in group C. At 30 and 60 min after reperfusion the maximum systemic rhTN F alpha concentrations were significantly higher in group B with 68 and 61 ng/ml compared to 14.5 and 14.9 ng/ml in group C (p < 0.05). Mean systemic porcine TNF alpha concentration was significantly higher in group B (217 pg /ml) compared to group C (50 pg/ml) 30 min after reperfusion (p = 0.012). S urvival was 7/9 in group A and C and only 2/9 in group B with 6/7 pigs dyin g due to severe cardiopulmonary failure within 12 h after operation. In sur viving pigs of group A and C only mild and transient hepatotoxicity was reg istered, The presented study underlines the feasibility of high dose rhTNF alpha application in an isolated hyperthermic liver perfusion system. Washo ut of the liver with a protein solution before reperfusion reduces systemic TNF alpha levels as well as associated lethal cardiocirculatory and hepato toxic side effects. Copyright (C) 2000 S. Karger AG, Basel.